Simplex Trading’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.6K Buy
2,500
+1,000
+67% +$4.1K ﹤0.01% 7399
2025
Q4
$5.57K Buy
1,500
+100
+7% +$858 ﹤0.01% 7374
2025
Q3
$19K Sell
1,400
-6,200
-82% -$96.7K ﹤0.01% 7375
2025
Q2
$145K Sell
7,600
-61,700
-89% -$963K ﹤0.01% 4843
2025
Q1
$766K Buy
69,300
+64,573
+1,366% +$770K ﹤0.01% 2958
2024
Q4
$78K Buy
4,727
+4,447
+1,588% +$55.5K ﹤0.01% 5414
2024
Q3
$2K Sell
280
-8,887
-97% -$264K ﹤0.01% 8046
2024
Q2
$529K Sell
9,167
-346
-4% -$17K ﹤0.01% 3612
2024
Q1
$316K Buy
9,513
+8,880
+1,403% +$450K ﹤0.01% 4325
2023
Q4
$51K Sell
633
-187
-23% -$15.2K ﹤0.01% 6063
2023
Q3
$133K Buy
+820
New +$194K ﹤0.01% 4804
2023
Q1
Sell
-40
Closed -$15K 9816
2022
Q4
$15K Sell
40
-13
-25% -$3.67K ﹤0.01% 7156
2022
Q3
$12K Buy
53
+20
+61% +$5.36K ﹤0.01% 8082
2022
Q2
$7K Sell
33
-834
-96% -$359K ﹤0.01% 8607
2022
Q1
$590K Sell
867
-73
-8% -$43.9K ﹤0.01% 3626
2021
Q4
$649K Buy
+940
New +$695K ﹤0.01% 3465

Other funds holding OM

Simplex Trading's OM Position: Q1 2026 in Review

Simplex Trading increased its Outset Medical (OM) stake by 17% in Q1 2026, buying an estimated $4.07K and bringing the position to 7,017 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6498.

Simplex Trading first reported a position in OM in Q1 2022 and has held it in 11 quarters since. The position peaked at $291K in Q2 2024. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Simplex Trading held 7,017 shares of Outset Medical worth $26.9K as of Q1 2026.
  • Simplex Trading bought 994 Outset Medical shares in Q1 2026, an estimated $4.07K.
  • Outset Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6498 holding.
  • Simplex Trading first reported a position in Outset Medical in Q1 2022 and has held it in 11 quarters since.
  • Simplex Trading's Outset Medical position peaked at $291K in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.